MCK Quote, Financials, Valuation and Earnings

Cardinal Health has a net margin of 1.39% compared to McKesson's net margin of 0.92%. McKesson's return on equity of -- beat Cardinal Health's return on equity of --.

McKesson has a consensus price target of $767.17, signalling upside risk potential of 7.19%. On the other hand Cardinal Health has an analysts' consensus of $176.41 which suggests that it could grow by 9.5%. Given that Cardinal Health has higher upside potential than McKesson, analysts believe Cardinal Health is more attractive than McKesson.

McKesson has a beta of 0.482, which suggesting that the stock is 51.795% less volatile than S&P 500. In comparison Cardinal Health has a beta of 0.675, suggesting its less volatile than the S&P 500 by 32.48%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.4%. Cardinal Health offers a yield of 1.26% to investors and pays a quarterly dividend of $0.51 per share. McKesson pays 10.47% of its earnings as a dividend. Cardinal Health pays out 58.57% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $90.8B, which are larger than Cardinal Health quarterly revenues of $54.9B. McKesson's net income of $1.3B is higher than Cardinal Health's net income of $506M. Notably, McKesson's price-to-earnings ratio is 27.71x while Cardinal Health's PE ratio is 25.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus 0.18x for Cardinal Health. Usually stocks with elevated PS ratios are considered overvalued.

Cencora has a net margin of 1.39% compared to McKesson's net margin of 0.95%. McKesson's return on equity of -- beat Cencora's return on equity of 183.42%.

McKesson has a consensus price target of $767.17, signalling upside risk potential of 7.19%. On the other hand Cencora has an analysts' consensus of $324.30 which suggests that it could grow by 8.89%. Given that Cencora has higher upside potential than McKesson, analysts believe Cencora is more attractive than McKesson.

McKesson has a beta of 0.482, which suggesting that the stock is 51.795% less volatile than S&P 500. In comparison Cencora has a beta of 0.571, suggesting its less volatile than the S&P 500 by 42.922%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.4%. Cencora offers a yield of 0.73% to investors and pays a quarterly dividend of $0.55 per share. McKesson pays 10.47% of its earnings as a dividend. Cencora pays out 27.58% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $90.8B, which are larger than Cencora quarterly revenues of $75.5B. McKesson's net income of $1.3B is higher than Cencora's net income of $717.9M. Notably, McKesson's price-to-earnings ratio is 27.71x while Cencora's PE ratio is 34.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus 0.19x for Cencora. Usually stocks with elevated PS ratios are considered overvalued.

Henry Schein has a net margin of 1.39% compared to McKesson's net margin of 3.47%. McKesson's return on equity of -- beat Henry Schein's return on equity of 8.28%.

McKesson has a consensus price target of $767.17, signalling upside risk potential of 7.19%. On the other hand Henry Schein has an analysts' consensus of $76.42 which suggests that it could grow by 10.25%. Given that Henry Schein has higher upside potential than McKesson, analysts believe Henry Schein is more attractive than McKesson.

McKesson has a beta of 0.482, which suggesting that the stock is 51.795% less volatile than S&P 500. In comparison Henry Schein has a beta of 0.866, suggesting its less volatile than the S&P 500 by 13.426%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.4%. Henry Schein offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.47% of its earnings as a dividend. Henry Schein pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $90.8B, which are larger than Henry Schein quarterly revenues of $3.2B. McKesson's net income of $1.3B is higher than Henry Schein's net income of $110M. Notably, McKesson's price-to-earnings ratio is 27.71x while Henry Schein's PE ratio is 21.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus 0.69x for Henry Schein. Usually stocks with elevated PS ratios are considered overvalued.

Pineapple has a net margin of 1.39% compared to McKesson's net margin of --. McKesson's return on equity of -- beat Pineapple's return on equity of --.

McKesson has a consensus price target of $767.17, signalling upside risk potential of 7.19%. On the other hand Pineapple has an analysts' consensus of -- which suggests that it could fall by --. Given that McKesson has higher upside potential than Pineapple, analysts believe McKesson is more attractive than Pineapple.

McKesson has a beta of 0.482, which suggesting that the stock is 51.795% less volatile than S&P 500. In comparison Pineapple has a beta of 35.438, suggesting its more volatile than the S&P 500 by 3443.784%.

McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.4%. Pineapple offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.47% of its earnings as a dividend. Pineapple pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

McKesson quarterly revenues are $90.8B, which are larger than Pineapple quarterly revenues of --. McKesson's net income of $1.3B is higher than Pineapple's net income of --. Notably, McKesson's price-to-earnings ratio is 27.71x while Pineapple's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus 81.14x for Pineapple. Usually stocks with elevated PS ratios are considered overvalued.